Profiles
profile image

Marie von Seyfried

Head of Global External Corporate Comms
AstraZeneca
UK

Perhaps uniquely in the world of pharma corporate communications leadership, Marie von Seyfried started her career as a nurse, in paediatric oncology at NYU Medical Centre. After crossing over into PR agency for a couple of years, she moved in-house and has spent the past 15 years in corporate comms roles within the healthcare, pharmaceutical and bioscience sector, first at Amgen, then onto Baxter and its spinoff Baxalta, then Shire and Vertex Pharma, before settling into her role as head of global external corporate communications at AstraZeneca in April 2019.

A year later, of course, and AstraZeneca was thrust, like the other pharma giants, firmly into the spotlight as Covid hit and the race for a vaccine was on, with von Seyfried quietly leading on media, corporate brand, and digital communications throughout the process of development of the “Oxford” vaccine. The generally successful roll-out hasn’t been without its controversies however – in June this year the first compensation payout was made for a death associated with the AstraZeneca jab.